This is a preview of subscription content, log in via an institution to check access.
Notes
The study was affiliated with, and funded by Vifor Pharma Group.
Costs were presented in 2020 pounds sterling, and included those for the treatments, healthcare professional time, and consumables.
Reference
Aksan A, et al. Evaluation of the Cost-Effectiveness of Iron Formulations for the Treatment of Iron Deficiency Anaemia in Patients with Inflammatory Bowel Disease in the UK ClinicoEconomics and Outcomes Research : 1 Jul 2021. Available from: URL: https://doi.org/10.2147/CEOR.S306823
Rights and permissions
About this article
Cite this article
Ferrous carboxymaltose cost effective for iron deficiency in IBD patients in the UK. PharmacoEcon Outcomes News 882, 12 (2021). https://doi.org/10.1007/s40274-021-7846-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-7846-1